Use of a combination comprising Lcarnitine or alkanoyl L-carnitine, lipid solubl benzoquinone and omega3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases

Details for Australian Patent Application No. 2006268787 (hide)

Owner Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

Inventors Feher, Janos; Gaetani, Franco

Agent Lord and Company

Pub. Number AU-B-2006268787

PCT Pub. Number WO2007/006672

Priority 05014812.1 08.07.05 EP

Filing date 30 June 2006

Wipo publication date 18 January 2007

Acceptance publication date 2 February 2012

International Classifications

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/202 (2006.01)

A61K 31/205 (2006.01)

A61K 31/221 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/006672 Priority application(s): WO2007/006672

2 February 2012 Application Accepted

  Published as AU-B-2006268787

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268788-Device for carrying out physiotherapeutic treatment

2006268785-N-Thio-anthranilamid compounds and their use as pesticides